Former president Donald Trump said Thursday that CBS News should lose a broadcasting license over how it edited a “60 Minutes” interview with Vice President Kamala Harris, even though the…
Latest News
-
-
One of the more consistent criticisms of the news media over the past decade or two has been that it is overly reliant on coverage of the “horse race” —…
-
The Gateway Pundit, a far-right news site that repeatedly published bogus stories claiming that the 2020 election was stolen, has settled a defamation lawsuit brought by Ruby Freeman and Shaye…
-
TD Bank pleaded guilty Thursday to multiple criminal charges and agreed to pay a whopping $3 billion in fines and other penalties to the Department of Justice and financial regulators for failing to…
-
TUCSON, Ariz. — In a stop here Wednesday afternoon, Sen. JD Vance told a crowd of supporters that “Trump’s message to illegal aliens who are in this country without any…
-
Former president Donald Trump on Thursday proposed new tax incentives and trade protections aimed at bolstering the U.S. car industry, as he battles Vice President Kamala Harris for crucial votes…
-
As Hurricane Milton approached landfall in western Florida on Wednesday, the Biden administration warned consumers and businesses of the heightened risk of potential fraud, price gouging and collusion that accompanies major natural…
-
Investing
Dynasty Gold Announces 2024 Annual General Meeting Results and Provides Thundercloud Drilling Update
Dynasty Gold Corp. (TSXV: DYG) (FSE: D5G1) (OTC Pink: DGDCF) (‘Dynasty’ or the ‘Company’) is pleased to report the results from its 2024 annual general meeting held on Friday, Oct.…
-
As Donald Trump and his allies spread false claims about Hurricanes Helene and Milton, the Republican Party has split into two camps: those who try to dispel the falsehoods, and…
-
Investing
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the…